Transdermal Drug Delivery System Market (Covid-19) Impact and Analysis By 2027 | Novartis Ag, Johnson & Johnson Services, Glaxosmithkline Bayer Ag, Mylan N.V., Boehringer Ingelheim International, Hisamitsu Pharmaceutical Co., Luye Pharma Group, Purdue Pha

The Insight Partners analysts forecasts the latest report on “Transdermal Drug Delivery System Market (Covid-19) Impact and Analysis by 2027”, according to report; The Transdermal Drug Delivery System Market report covers the overall and all-inclusive analysis of Market with all its factors that have an impact on market growth. This report is anchored on the thorough qualitative and quantitative assessment of the Transdermal Drug Delivery System Market.

The study provides details such as the market share, Market Insights, Strategic Insights, Segmentation and key players in the Transdermal Drug Delivery System Market.

Download Sample Report of Transdermal Drug Delivery System Market Report @ https://www.theinsightpartners.com/sample/TIPRE00002894/?openpr-10225

(*If you have any special requirements, please let us know and we will offer you the report as you want.)

The transdermal drug delivery system market was valued at US$ 6,063.85 million in 2019 and is projected to reach US$ 8,415.04 million 2027; it is expected to grow at a CAGR of 4.3% from 2020 to 2027.

Some of the Major Market Players Are:

Novartis Ag
Johnson & Johnson Services, Inc.
Glaxosmithkline Plc.
Bayer Ag
Mylan N.V.
Boehringer Ingelheim International Gmbh
Hisamitsu Pharmaceutical Co.,Inc.
Luye Pharma Group
Purdue Pharma L.P.
Lavipharm

Market Insights

Growing Demand for Non-Invasive Drug Delivery Devices

With the improvements in medical science and definite oral drug delivery technologies, the non-invasive mode of drug delivery system is now prepared to compete with traditional methods of injectable and painful routes of drug delivery. The non-invasive drug delivery systems include drug delivery via oral, topical, transdermal-active (device-aided enhanced penetration), transdermal-passive, trans-ocular membrane, trans-mucosal membrane, and via alveolar membrane from inhaled medication. Transdermal delivery has a range of advantages compared to the oral route. In particular, it is used when there is a significant first-pass effect of the liver that can impulsively metabolize drugs. Transdermal delivery also has advantages over hypodermic injections, which are painful, create dangerous medical waste, and pose the risk of disease transmission by needle re-use, especially in developing countries. Additionally, transdermal systems are non-invasive and can be self-administered. Patient compliance has been found to be much higher when administrated by non-invasive routes due to decreased pain involved in drug delivery. Therefore, these techniques are considered a preferred mode of drug delivery, thereby driving the market growth in the review period.

Type-Based Insights

Based on type, the transdermal drug delivery system market is segmented into transdermal patches and transdermal semisolids. The transdermal patch segment is further sub segmented into drug-in-adhesive patches, matrix patches, reservoir membrane patches, and micro needle patches. The transdermal semisolids segment is further sub segmented into gels, ointments, and sprays. The transdermal patches segment held the larger share of the market in 2019, owing to the advantages such as better patient compliance, faster onset of action, and improved permeability and efficacy. Also, the transdermal patches segment is expected to register a higher CAGR in the market during the forecast period. Additionally, growing emphasis on implementation of inorganic strategies to elevate manufacturing capacity is also projected to drive the transdermal patches segment growth. For instance, in August 2019, Canoa Inc. announced its plan to acquire privately-held ProSolus Inc. to accelerate transdermal drug delivery product development. This strategic acquisition will consolidate company’s transdermal drug delivery products manufacturing capacity.

Application-Based Insights

Based on application, the transdermal drug delivery system market is segmented into pain management, central nervous system disorders, hormonal applications, cardiovascular diseases, and other applications. The hormonal applications segment is further sub segmented into transdermal estrogen therapy and testosterone replacement. In 2019, the pain management segment accounted for the largest share of the global transdermal drug delivery system market owing to increasing number of transdermal drug delivery systems for the pain management. Also, pain management segment is estimated to register the highest CAGR in the market during the forecast period.

End User-Based Insights

Based on end user, the transdermal drug delivery system market is further segmented into hospitals and clinics, home care settings, and others. The hospitals and clinics segment held the largest share of the market in 2019, owing to increasing emphasis on adoption of transdermal drug delivery systems in clinics. Hospitals serve a significant role by providing extensive range of medical services to the patient population suffering from wide variety of diseases. This increased the adoption of drug delivery systems in hospitals and clinics.

Strategic Insights

Product launches and expansion strategy is commonly adopted by companies to expand their footprint worldwide and meet the growing demand. This strategy is most commonly adopted by the market players in order to expand its product portfolio.

The market players operating in the transdermal drug delivery system market adopted the strategy of product innovation to cater to changing customer demand across the world, which also permits the players to maintain their brand name globally.

The report segments global transdermal drug delivery system market as follows:

By Type

• Transdermal Patches
o Matrix Patches
o Microneedle Patches
o Drug-In-Adhesive Patches
o Reservoir Membrane Patches
• Transdermal Semisolids
o Sprays
o Gels
o Ointments

By Application

• Cardiovascular Diseases
• Central Nervous System Disorders
• Pain Management
• Hormonal Applications
o Transdermal Estrogen Therapy
o Testosterone Replacement Therapy
• Other Applications

By End User

• Hospitals and Clinics
• Home Care Settings
• Other End Users

The report analyses factors affecting the Transdermal Drug Delivery System Market from further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Transdermal Drug Delivery System Market in these regions.

Moreover, the report entails the estimate and analysis for the Transdermal Drug Delivery System Market on a global as well as regional level. The study provides historical data as well as the trending features and future predictions of the market growth. Further, the report encompasses drivers and restraints for the Transdermal Drug Delivery System Market growth along with its impact on the overall market development. In addition, the report provides an analysis of the accessible avenues in the market on a global level.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global Transdermal Drug Delivery System Market based on various segments. It also provides market size and forecast estimates from the year 2018 to 2027 with respect to five major regions. The Transdermal Drug Delivery System Market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

Promising Regions & Countries Mentioned in The Transdermal Drug Delivery System Market Report:

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East & Africa

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Major Features of Transdermal Drug Delivery System Market Report:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Transdermal Drug Delivery System market
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global Transdermal Drug Delivery System market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution.

Purchase a copy of Transdermal Drug Delivery System Market research report @ https://www.theinsightpartners.com/buy/TIPRE00002894/?openpr-10225

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

This release was published on openPR.